|
Volumn 2, Issue 2, 2012, Pages 151-153
|
Diagnostic tests for Alzheimer disease: FDG-PET imaging is a player in search of a role
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
FLUORODEOXYGLUCOSE F 18;
ALZHEIMER DISEASE;
ARTICLE;
BRAIN METABOLISM;
CEREBROVASCULAR DISEASE;
COGNITIVE DEFECT;
COMORBIDITY;
DAILY LIFE ACTIVITY;
DEMENTIA;
DIAGNOSTIC ACCURACY;
DIFFERENTIAL DIAGNOSIS;
DIFFUSE LEWY BODY DISEASE;
FRONTOTEMPORAL DEMENTIA;
HUMAN;
MEDICAID;
MEDICARE;
MILD COGNITIVE IMPAIRMENT;
NEUROIMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RADIATION EXPOSURE;
SENSITIVITY AND SPECIFICITY;
THORAX RADIOGRAPHY;
|
EID: 84876509061
PISSN: 21630402
EISSN: 21630933
Source Type: Journal
DOI: 10.1212/CPJ.0b013e31825a7801 Document Type: Article |
Times cited : (8)
|
References (5)
|